Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists launch major effort to unlock secrets of rare brain disease CADASIL

NCT ID NCT05677880

First seen Jan 18, 2026 · Last updated Jun 20, 2026 · Updated 31 times

Summary

This study follows 660 adults with CADASIL, a genetic condition that causes strokes and dementia, for up to 5 years. Researchers will use brain scans, memory tests, and blood samples to track how the disease progresses from its earliest stages. The goal is to identify factors that influence disease onset and severity, which could help develop future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CADASIL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brown University

    RECRUITING

    Providence, Rhode Island, 02912, United States

  • Columbia University

    RECRUITING

    New York, New York, 10027, United States

  • Georgia State University Research Foundation

    RECRUITING

    Atlanta, Georgia, 30303, United States

  • Loyola University

    RECRUITING

    Chicago, Illinois, 60660, United States

  • Oregon Health & Science University

    RECRUITING

    Portland, Oregon, 97239, United States

  • University of California

    RECRUITING

    Los Angeles, California, 90095, United States

  • University of California

    RECRUITING

    San Francisco, California, 94143, United States

  • University of Colorado

    RECRUITING

    Denver, Colorado, 80204, United States

  • University of Texas

    NOT_YET_RECRUITING

    San Antonio, Texas, 78249, United States

  • University of Texas Health Science Center

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84112, United States

  • University of Washington

    RECRUITING

    Seattle, Washington, 98195, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal early markers and risk factors for CADASIL, pointing toward ways to slow or predict the disease.

What could go wrong

This is an observational study, not a treatment trial. It may not lead to any direct therapy, and results may take years to translate into clinical practice.

Conditions

The condition(s) this trial relates to.

cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Cognitive Dysfunction dementia Nerve Degeneration vascular dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.